The essentials

Vitiligo causes milk-white patches when the immune system destroys the cells that color the skin. It is not contagious and not dangerous, but it often travels with thyroid disease. No blood test diagnoses vitiligo; doctors use a blood test to check the thyroid (TSH, sometimes thyroid antibodies). Treatments such as creams and light therapy can bring back color, especially on the face.

What is vitiligo, at a glance?

Vitiligo is a long-term condition in which pigment cells (melanocytes) stop working or are destroyed, leaving pale or white patches[8]. It is now classified as an autoimmune disease[6], one of the many covered in our guide to autoimmune diseases and their blood tests.

Vitiligo in brief
TopicKey facts
Other namesLeukoderma; "white spot disease" (in German, Weißfleckenkrankheit)
How commonAbout 0.36% of people worldwide have a diagnosis[1]; 0.76% to 1.11% of US adults, and about 40% of them do not know it[2]
Usual ageAny age, on average in the mid-twenties[9]
Key testsSkin examination, sometimes under a Wood's lamp; TSH and thyroid antibodies to look for thyroid disease[8][4]
Linked conditions15% to 25% have at least one other autoimmune disease[9], thyroid disease first

What are the first signs and symptoms of vitiligo?

The patches look lighter than the usual skin tone, then white; they may look pink, and their edge is sometimes reddish or brownish[8]. They are flat, not scaly, and rarely itch[8].

  • Common Non-segmental vitiligo (about 9 in 10 people): patches on both sides of the body, often around the mouth and eyes, on the fingers, wrists, armpits, groin and genitals[8]. It tends to spread slowly over a lifetime[11].
  • Possible Segmental vitiligo: patches on one side or one area only. It is more frequent in children (about 3 in 10 children with vitiligo)[8], spreads for 6 to 12 months, then usually stops[11].
  • Possible White or gray hair in a patch, on the scalp, eyebrows, eyelashes or beard[8].
  • Rare Universal vitiligo, affecting almost all the skin[8]; inflammation inside the eye (uveitis) or partial hearing loss[8].

New patches often appear where the skin was rubbed, cut or burned, a reaction called the Koebner phenomenon[7].

When to see a doctor

  • Emergency: call 911 for severe weakness, fainting, vomiting and belly pain, which can reveal an adrenal crisis in someone with Addison's disease, a rare companion of autoimmune conditions.
  • Within 24 to 48 hours for a painful red eye with blurred vision or sensitivity to light, or for marked thirst with frequent urination and weight loss (possible diabetes)[8].
  • At your next appointment for any new pale or white patch, patches that spread, or tiredness, weight change or feeling cold that could point to the thyroid[8].

What causes vitiligo, and is it genetic or contagious?

In non-segmental vitiligo, the immune system attacks melanocytes[8]. Segmental vitiligo is thought to involve substances released by nerve endings in the skin[8], though immune mechanisms probably play a part in all forms[7].

  • Genes: variations in more than 30 genes raise the risk, and about 1 person in 5 has a close relative with vitiligo[9]. It is a tendency, not a disease passed on directly.
  • Triggers: a stressful event such as childbirth, skin injury such as severe sunburn, hormonal changes such as puberty, or contact with certain chemicals[8].
  • Not contagious: vitiligo cannot be caught from someone or passed to anyone[10][8].

How is vitiligo diagnosed, and which blood tests are checked?

The diagnosis is made by looking at the skin and asking about family history, injuries and how the patches changed[8]. A Wood's lamp (ultraviolet light in a dark room) makes the patches stand out and helps tell vitiligo from a common fungal rash, pityriasis (tinea) versicolor[8][10]. A skin biopsy is rarely needed.

Blood tests do not prove vitiligo. They look for the autoimmune diseases that come with it[10]. In a US clinic of 1,098 patients, 12.9% had thyroid disease, 3.8% alopecia areata and 0.5% pernicious anemia[3]. A meta-analysis of 37 studies found thyroid disease about 4 times more often than in people without vitiligo, mainly in non-segmental vitiligo, and its authors advise routine screening for thyroid antibodies[4]. Here is a fictitious report for a 34-year-old woman with new patches.

Fictitious example of a lab report after a vitiligo diagnosis (United States format)
TestResultReference rangeFlag
TSH6.2 mIU/L0.45-4.50 mIU/LH
FT4 (thyroxine)1.1 ng/dL0.8-1.8 ng/dL
Thyroid peroxidase antibodies (TPO Ab)180 IU/mLLess than 35 IU/mLH
Hemoglobin13.4 g/dL12.0-15.5 g/dL
Vitamin B12410 pg/mL200-900 pg/mL
Glucose, fasting88 mg/dL70-99 mg/dL
  1. TSH high, FT4 normal: the pattern of a mildly underactive thyroid, often called subclinical hypothyroidism. One result is repeated before any decision.
  2. TPO antibodies high: the immune system is also targeting the thyroid, as in Hashimoto's thyroiditis. Vitiligo multiplies the odds of positive TPO antibodies by about 3.8[4].
  3. Normal lines: hemoglobin, B12 and glucose are not routine for every patient; doctors add them when symptoms suggest anemia or diabetes[8]. Ranges vary by laboratory: yours applies.

Thyroid results flagged after a vitiligo diagnosis? BloodSense explains each line of your report in plain words, so you know what to discuss at your next visit.

Explain my blood test

Each marker has its own guide: TSH blood test, anti-TPO antibodies, thyroid panel, vitamin B12 levels, complete blood count and HbA1c. Thyroid disease linked to vitiligo can also be an overactive thyroid, such as Graves' disease[8].

Which tests are used to follow vitiligo?

  • The skin itself: doctors judge activity patch by patch[7]. Vitiligo counts as active when spots appeared or grew within the past 12 months[10]; dated photos taken in the same light help.
  • The thyroid: there is no single schedule for everyone. Ask when to repeat TSH, especially if antibodies are positive: in a 20-year British study, women with both a raised TSH and thyroid antibodies were 38 times more likely to develop an underactive thyroid[12].
  • Later onset: thyroid disease was more frequent when vitiligo started in adulthood than in childhood[4].
  • Other tests on symptoms: blood count and B12 for unusual tiredness or pallor, glucose or HbA1c for thirst, cortisol tests for weakness and weight loss[3][8].

How is vitiligo treated?

Treatment is optional: it is worth it when the patches are distressing[8]. It can bring back color but rarely makes every patch disappear for good[8].

  • Creams: corticosteroids for a limited time, because they thin the skin; tacrolimus ointment or pimecrolimus cream, which suit the face and neck[10].
  • Ruxolitinib cream (a JAK inhibitor): FDA-approved from age 12 for non-segmental vitiligo on small areas[10]. In two trials of 674 patients, about 30% regained at least 75% of facial color at 24 weeks, versus 7% to 11% with a plain cream; acne and itch at the site were the usual side effects[5].
  • Light therapy (narrowband UVB, or laser for small areas), alone or with a cream; several sessions are needed[10].
  • Steroid tablets for a short time when new spots keep appearing[10].
  • Surgery (skin or cell grafts) for stable patches only, not for active vitiligo[10].
  • Depigmentation, for people who have lost most of their color: a cream removes the remaining pigment over 1 to 4 years, permanently[10].

About 40% of people see some color fade within a year of stopping treatment[10]. Treating a thyroid problem does not bring back skin color: the two are followed separately.

Can vitiligo be prevented, and how do you live with it?

There is no known way to prevent it. Diet and supplements have not been shown to treat it[10].

  • Protect the patches from the sun with a high-SPF sunscreen: they burn easily[8].
  • Avoid friction, tight clothing and cuts on the skin when you can, since injuries can trigger new patches[7].
  • Camouflage makeup or a self-tanner evens the skin tone right away[10].
  • Keep your thyroid results together to compare them over time.
  • Speak up if vitiligo affects your mood or confidence: this is common, and support groups exist[8].

Questions to ask your doctor

  1. Is my vitiligo segmental or non-segmental, and is it active?
  2. Should my thyroid be checked, and do I need the antibody test too?
  3. If the antibodies are positive, when should I repeat TSH?
  4. Which treatment suits my face, hands or body, and for how long?

Frequently asked questions

Can vitiligo go away on its own?

Patches are usually permanent[8]. Treatment can bring back some color, and segmental vitiligo usually stops spreading after a year or so[11].

Does vitiligo raise the risk of skin cancer?

No, vitiligo patches do not raise skin cancer risk, but they sunburn easily and the rest of the skin can still develop cancer[11]. See our guide to skin cancer warning signs.

Is a vitamin deficiency the cause of white patches?

Not in vitiligo: no vitamin causes it, and supplements have not been shown to treat it[10]. B12 is tested only when anemia is suspected, since pernicious anemia is slightly more common with vitiligo[3].

Does vitiligo affect children?

Yes. Children more often have the segmental form[8], and thyroid disease is less frequent when vitiligo starts early[4].

References

  1. Akl J, Lee S, Ju HJ, et al. Estimating the burden of vitiligo: a systematic review and modelling study. Lancet Public Health. 2024;9(6):e386-e396. doi:10.1016/S2468-2667(24)00026-4 (accessed November 21, 2026)
  2. Gandhi K, Ezzedine K, Anastassopoulos KP, et al. Prevalence of Vitiligo Among Adults in the United States. JAMA Dermatol. 2022;158(1):43-50. doi:10.1001/jamadermatol.2021.4724 (accessed November 21, 2026)
  3. Gill L, Zarbo A, Isedeh P, et al. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study. J Am Acad Dermatol. 2016;74(2):295-302. doi:10.1016/j.jaad.2015.08.063 (accessed November 21, 2026)
  4. Fan KC, Yang TH, Huang YC. Vitiligo and thyroid disease: a systematic review and meta-analysis. Eur J Dermatol. 2018;28(6):750-763. doi:10.1684/ejd.2018.3449 (accessed November 21, 2026)
  5. Rosmarin D, Passeron T, Pandya AG, et al. Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. N Engl J Med. 2022;387(16):1445-1455. doi:10.1056/NEJMoa2118828 (accessed November 21, 2026)
  6. Bergqvist C, Ezzedine K. Vitiligo: A Review. Dermatology. 2020;236(6):571-592. doi:10.1159/000506103 (accessed November 21, 2026)
  7. Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res. 2012;25(3):E1-E13. doi:10.1111/j.1755-148X.2012.00997.x (accessed November 21, 2026)
  8. NHS. Vitiligo. Reviewed March 22, 2023. nhs.uk (accessed November 21, 2026)
  9. MedlinePlus Genetics. Vitiligo. US National Library of Medicine. Updated February 24, 2022. medlineplus.gov (accessed November 21, 2026)
  10. American Academy of Dermatology. Vitiligo: Diagnosis and treatment. Updated April 15, 2026. aad.org (accessed November 21, 2026)
  11. American Academy of Dermatology. Vitiligo: Overview. Updated April 14, 2026. aad.org (accessed November 21, 2026)
  12. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68. doi:10.1111/j.1365-2265.1995.tb01894.x (accessed November 21, 2026)

General information only: it does not replace the advice of the doctor who examines your skin and knows your full results.